Coronary Stents: Procurement Documentation and Reference Matching

A procurement guide to stent identity, size matrices, platform documentation, shelf life and traceability. The purpose is to help teams make a clearer, better documented decision without turning a commercial checklist into a clinical recommendation.

Quick answer

Stent orders are vulnerable to wrong generation, diameter, length or reference when buyers rely on abbreviated family names. A stronger approach produces a traceable purchase record tied to the exact clinician approved stent variant.

This cluster article supports the broader guide on Interventional Cardiology Devices: A Procurement Guide. The main search topic for this guide is coronary stent procurement. Related language includes coronary stent sizes, stent reference number, drug eluting stent purchasing, but the article uses those terms only where they help the reader rather than repeating them mechanically.

Why this matters

Interventional cardiology purchasing is reference sensitive. A product family can contain many sizes, lengths, curves, coatings and delivery configurations. Procurement should verify the approved requirement, not infer clinical suitability from a catalogue description.

For cath lab procurement, quality, stores and cardiology operations, the practical risk is not limited to price. A wrong reference, incomplete pack, uncertain shelf life, late shipment or unsupported alternative can create rework, unused inventory and avoidable delays. A useful buying process therefore connects the technical request, commercial offer and receiving standard.

The best time to resolve ambiguity is before the purchase order. Once goods are dispatched, every unclear field becomes harder and more expensive to correct. The controls below are designed to move important questions to the beginning of the process.

Key checks

These checks should be adapted to product risk and organisational policy. A routine low risk item and a sterile implantable or procedure critical device should not automatically receive the same depth of review.

A practical workflow

1. Step 1: Obtain the approved stent family and size list. Record the owner, evidence and completion date so the action can be checked later.
2. Step 2: Verify current references against manufacturer information. Record the owner, evidence and completion date so the action can be checked later.
3. Step 3: Send one RFQ line for each size. Record the owner, evidence and completion date so the action can be checked later.
4. Step 4: Require suppliers to disclose region, pack and expiry. Record the owner, evidence and completion date so the action can be checked later.
5. Step 5: Review substitutions with clinical and quality stakeholders. Record the owner, evidence and completion date so the action can be checked later.
6. Step 6: Record lot and expiry when stock is received. Record the owner, evidence and completion date so the action can be checked later.

A workflow is only useful when exceptions are visible. If a field is unknown, mark it as unknown and assign an owner. Do not fill the gap with an assumption merely to complete the form. The decision record should show what was confirmed, what remained conditional and which stakeholder accepted the residual risk.

Documentation and verification

Current manufacturer labelling and instructions are the primary product specific sources. Procurement teams can confirm identity, pack, expiry and compatibility statements, while clinical selection and use remain the responsibility of qualified healthcare professionals.

Every RFQ line should be traceable to an exact approved variant. Proposed alternatives need their own line, supporting documents and named clinical approval. This separation protects both the buyer and the supplier from accidental substitution.

For every important document, record the document title, issuing organisation, product or company scope, version or validity date, source and date reviewed. This simple index helps prevent a valid document from being attached to the wrong product or reused after it becomes outdated.

Minimum decision record

• The original request and clinician or technical approval where required
• The exact quoted product identity, pack and quantity
• Supplier assumptions, deviations and proposed alternatives
• Quality, regulatory and traceability evidence proportionate to risk
• Price basis, landed cost assumptions, lead time and shelf life
• Approval names, dates and any conditions
• Receiving checks and final disposition of discrepancies

Questions to ask before approval

• Can the supplier demonstrate the product generation described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the diameter and length described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the delivery system described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the shelf life described in the RFQ, and can the answer be connected to the exact quoted product?
• Can the supplier demonstrate the traceability described in the RFQ, and can the answer be connected to the exact quoted product?

Ask suppliers to answer against each RFQ line rather than in a general email. A line level response makes it easier to compare offers, detect partial matches and transfer the approved information into the purchase order.

Common mistakes

• Using one line for assorted sizes without a quantity breakdown. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Mixing stent generations in the same item record. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Accepting short dated slow moving sizes without a plan. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.
• Failing to retain lot level receiving information. Correct it by returning to the approved requirement, recording the missing evidence and resolving the gap before the order or release decision.

Most procurement errors are not caused by one dramatic failure. They develop through several small gaps, such as an abbreviated name, an unrecorded assumption and a receiving check that compares quantity but not reference. Closing those gaps consistently is more effective than adding a large document request after a problem occurs.

Practical example

The lesson is not that every enquiry must become slow. A structured template is usually faster because it reduces repeated emails and makes approval requirements visible from the start.

Final checklist

• ✓ Product generation has been reviewed: Record the complete commercial name and generation.
• ✓ Diameter and length has been reviewed: List every required size as a separate line item.
• ✓ Delivery system has been reviewed: Verify the approved system details and compatibility from current documentation.
• ✓ Shelf life has been reviewed: Set minimum remaining shelf life before accepting stock.
• ✓ Traceability has been reviewed: Capture reference, lot, expiry and UDI information at receipt where applicable.

Before closing the file, confirm that the purchase order reflects the approved quotation rather than an earlier draft. At receiving, compare the physical label and condition with the same approved record. This completes the link between request, order and delivered product.

Frequently asked questions

Related AJA guides

• Interventional Cardiology Devices: A Procurement GuideA procurement focused overview of common interventional cardiology device groups, specification control and compatibility review.
• Coronary Guidewire Selection: What Procurement Teams Need to SpecifyA non clinical specification checklist for accurate coronary guidewire enquiries and purchasing records.
• Coronary Balloon Catheters: RFQ and Compatibility ChecklistA buyer checklist for dimensions, pressure data, guidewire compatibility, catheter length and exact balloon references.
• Guiding Catheters vs Diagnostic Catheters: A Buyer GuideA procurement comparison of two catheter categories, with emphasis on intended role, French size, curve, length and reference identity.

Browse the medical device product catalogue, review the brand sourcing profiles or read about AJA International’s quality and compliance approach.

Official resources and further reading

• FDA medical device information
• European Commission medical devices sector
• MedTech Europe medical technology overview

Editorial review: Prepared for publication in 2026. Regulatory, registration and product information can change, so readers should confirm current requirements and manufacturer documentation before acting.